Literature DB >> 26389695

Ajuba Preferentially Binds LXRα/RXRγ Heterodimer to Enhance LXR Target Gene Expression in Liver Cells.

Hongyan Fan1, Weibing Dong1, Qi Li1, Xiuqun Zou1, Yihong Zhang1, Jiamin Wang1, Shengxian Li1, Wei Liu1, Ying Dong1, Haipeng Sun1, Zhaoyuan Hou1.   

Abstract

The liver X receptors (LXRs) are important regulators of lipid, cholesterol, and glucose homeostasis by transcriptional regulation of many key genes in these processes, and the transcriptional activities of LXRs are finely controlled by cooperating with retinoid X receptors and many other coregulators. Here, we report that the LIM protein Ajuba binds to the hinge and the ligand binding domains of LXRα via its C-terminal tandem LIM motifs and enhances LXR target gene expression in liver cells. Depletion of Ajuba in HepG2 cells and in mouse primary hepatocytes decreases LXR target gene expression, whereas stable expression of Ajuba in HepG2 cells results in increased expression of these genes. Mechanistic investigations found that Ajuba selectively interacts with LXRα/retinoid X receptor-γ heterodimer to form a ternary complex, which displays a higher transactivation activity to LXR target genes. Moreover, Ajuba and LXR mutually affect their DNA binding activity at endogenous target chromatins and the cooperation between Ajuba and LXRα is dependent on the functional LXR response elements located in the target promoters. Together, our studies demonstrate that Ajuba is a novel coactivator for LXRs and may play important role in lipid and glucose metabolism.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 26389695      PMCID: PMC5414675          DOI: 10.1210/me.2015-1046

Source DB:  PubMed          Journal:  Mol Endocrinol        ISSN: 0888-8809


  31 in total

1.  Ajuba, a cytosolic LIM protein, shuttles into the nucleus and affects embryonal cell proliferation and fate decisions.

Authors:  J Kanungo; S J Pratt; H Marie; G D Longmore
Journal:  Mol Biol Cell       Date:  2000-10       Impact factor: 4.138

Review 2.  Biological role of liver X receptors.

Authors:  M Baranowski
Journal:  J Physiol Pharmacol       Date:  2008-12       Impact factor: 3.011

3.  The nuclear receptor LXR is a glucose sensor.

Authors:  Nico Mitro; Puiying A Mak; Leo Vargas; Cristina Godio; Eric Hampton; Valentina Molteni; Andreas Kreusch; Enrique Saez
Journal:  Nature       Date:  2006-12-24       Impact factor: 49.962

4.  Ajuba LIM proteins are negative regulators of the Hippo signaling pathway.

Authors:  Meghna Das Thakur; Yunfeng Feng; Radhika Jagannathan; Midori J Seppa; James B Skeath; Gregory D Longmore
Journal:  Curr Biol       Date:  2010-03-18       Impact factor: 10.834

5.  Orphan nuclear receptor DAX-1 acts as a novel corepressor of liver X receptor alpha and inhibits hepatic lipogenesis.

Authors:  Balachandar Nedumaran; Gwang Sik Kim; Sungpyo Hong; Young-Sil Yoon; Yong-Hoon Kim; Chul-Ho Lee; Young Chul Lee; Seung-Hoi Koo; Hueng-Sik Choi
Journal:  J Biol Chem       Date:  2010-01-15       Impact factor: 5.157

6.  The LIM protein AJUBA recruits protein arginine methyltransferase 5 to mediate SNAIL-dependent transcriptional repression.

Authors:  Zhaoyuan Hou; Hongzhuang Peng; Kasirajan Ayyanathan; Kai-Ping Yan; Ellen M Langer; Gregory D Longmore; Frank J Rauscher
Journal:  Mol Cell Biol       Date:  2008-03-17       Impact factor: 4.272

7.  Anatomical profiling of nuclear receptor expression reveals a hierarchical transcriptional network.

Authors:  Angie L Bookout; Yangsik Jeong; Michael Downes; Ruth T Yu; Ronald M Evans; David J Mangelsdorf
Journal:  Cell       Date:  2006-08-25       Impact factor: 41.582

8.  The LIM protein Ajuba influences p130Cas localization and Rac1 activity during cell migration.

Authors:  Stephen J Pratt; Holly Epple; Michael Ward; Yunfeng Feng; Vania M Braga; Gregory D Longmore
Journal:  J Cell Biol       Date:  2005-02-22       Impact factor: 10.539

9.  SIRT1 deacetylates and positively regulates the nuclear receptor LXR.

Authors:  Xiaoling Li; Songwen Zhang; Gil Blander; Jeanette G Tse; Monty Krieger; Leonard Guarente
Journal:  Mol Cell       Date:  2007-10-12       Impact factor: 17.970

10.  Ursodeoxycholic acid inhibits liver X receptor α-mediated hepatic lipogenesis via induction of the nuclear corepressor SMILE.

Authors:  Ji-Min Lee; Gil-Tae Gang; Don-Kyu Kim; Yong Deuk Kim; Seung-Hoi Koo; Chul-Ho Lee; Hueng-Sik Choi
Journal:  J Biol Chem       Date:  2013-11-21       Impact factor: 5.157

View more
  5 in total

Review 1.  An emerging link between LIM domain proteins and nuclear receptors.

Authors:  Stefano Sala; Christophe Ampe
Journal:  Cell Mol Life Sci       Date:  2018-02-10       Impact factor: 9.261

2.  Hypercholesterolemia and 27-Hydroxycholesterol Increase S100A8 and RAGE Expression in the Brain: a Link Between Cholesterol, Alarmins, and Neurodegeneration.

Authors:  Raúl Loera-Valencia; Muhammad-Al-Mustafa Ismail; Julen Goikolea; Maria Lodeiro; Laura Mateos; Ingemar Björkhem; Elena Puerta; Mariana A Romão; Cláudio M Gomes; Paula Merino-Serrais; Silvia Maioli; Angel Cedazo-Minguez
Journal:  Mol Neurobiol       Date:  2021-08-27       Impact factor: 5.590

3.  The LIM domain protein nTRIP6 acts as a co-repressor for the transcription factor MEF2C in myoblasts.

Authors:  Denise Kemler; Oliver Dahley; Sven Roßwag; Margarethe Litfin; Olivier Kassel
Journal:  Sci Rep       Date:  2016-06-13       Impact factor: 4.379

4.  Ajuba inhibits hepatocellular carcinoma cell growth via targeting of β-catenin and YAP signaling and is regulated by E3 ligase Hakai through neddylation.

Authors:  Min Liu; Ke Jiang; Guibin Lin; Peng Liu; Yumei Yan; Tian Ye; Gang Yao; Martin P Barr; Dapeng Liang; Yang Wang; Peng Gong; Songshu Meng; Haozhe Piao
Journal:  J Exp Clin Cancer Res       Date:  2018-07-24

5.  The LIM protein Ajuba recruits DBC1 and CBP/p300 to acetylate ERα and enhances ERα target gene expression in breast cancer cells.

Authors:  Beihui Xu; Qi Li; Ning Chen; Chunxiao Zhu; Qingrong Meng; Kasirajan Ayyanathan; Wenli Qian; Hao Jia; Jiamin Wang; Peihua Ni; Zhaoyuan Hou
Journal:  Nucleic Acids Res       Date:  2019-03-18       Impact factor: 16.971

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.